HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoko Matsushita Selected Research

tomopenem

12/2010In vivo pharmacodynamic activity of tomopenem (formerly CS-023) against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.
8/2005In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoko Matsushita Research Topics

Disease

7Chronic Hepatitis C
08/2015 - 01/2013
4Fibrosis (Cirrhosis)
12/2014 - 11/2009
4Ascites
08/2014 - 03/2009
3Neoplasms (Cancer)
10/2018 - 06/2008
2Liver Cirrhosis (Hepatic Cirrhosis)
08/2014 - 01/2012
2Portal Hypertension
02/2014 - 05/2013
2Edema (Dropsy)
05/2013 - 01/2012
2Infections
12/2010 - 08/2005
1Cysts
01/2022
1Hydrocephalus (Hydrocephaly)
01/2022
1Meningioma (Meningiomas)
10/2018
1Vitamin D Deficiency
08/2015
1Hypersplenism (Anemia, Splenic)
01/2015
1Thrombocytopenia (Thrombopenia)
01/2015
1Lymphatic Metastasis
11/2014
1Genomic Instability
11/2014
1Tuberculosis (Tuberculoses)
07/2014
1Varicose Veins (Varicose Vein)
05/2013
1Angiodysplasia
05/2013
1Rectal Neoplasms (Rectal Cancer)
12/2011
1Liver Diseases (Liver Disease)
12/2011
1Hepatic Encephalopathy
01/2011
1Hepatorenal Syndrome
11/2009
1Residual Neoplasm
06/2008
1Bacterial Infections (Bacterial Infection)
08/2005

Drug/Important Bio-Agent (IBA)

5Ribavirin (Virazole)FDA LinkGeneric
01/2015 - 01/2013
4InterferonsIBA
01/2015 - 01/2013
3AlbuminsIBA
08/2015 - 01/2011
3telaprevirIBA
01/2015 - 07/2014
3Capsules (Microcapsules)IBA
05/2013 - 01/2012
2Calcifediol (Calcidiol)FDA Link
08/2015 - 12/2014
2CreatinineIBA
08/2014 - 01/2011
2FluvastatinFDA Link
07/2014 - 01/2013
2tomopenemIBA
12/2010 - 08/2005
1Boron-10IBA
10/2018
1Vitamin DFDA LinkGeneric
08/2015
1Hemoglobins (Hemoglobin)IBA
08/2015
1Protease Inhibitors (Protease Inhibitor)IBA
01/2015
1DNA HelicasesIBA
11/2014
1Aligeron (AS 2)IBA
07/2014
1fasudil (AT 877)IBA
02/2014
1InterleukinsIBA
03/2013
1Interferon-alpha (Interferon Alfa)IBA
03/2013
1alfacalcidolIBA
01/2013
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2013
1CarcinogensIBA
10/2012
1SteroidsIBA
12/2011
1Proteins (Proteins, Gene)FDA Link
12/2011
1BilirubinIBA
01/2011
1N 30IBA
01/2011
1TerlipressinIBA
11/2009
1Ceftazidime (Fortum)FDA LinkGeneric
08/2005
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
08/2005
1Meropenem (Merrem)FDA LinkGeneric
08/2005
1Imipenem Drug Combination Cilastatin (Primaxin)FDA Link
08/2005
1VancomycinFDA LinkGeneric
08/2005

Therapy/Procedure

8Therapeutics
01/2015 - 12/2011
4Transjugular Intrahepatic Portasystemic Shunt
08/2014 - 03/2009
4Surgical Portasystemic Shunt (Portosystemic Shunt)
08/2014 - 03/2009
1Cerebrospinal Fluid Shunts
01/2022
1Endoscopes
01/2022
1Boron Neutron Capture Therapy
10/2018
1Neutron Capture Therapy
10/2018
1Drug Therapy (Chemotherapy)
11/2014
1Punctures
06/2008